Influenza viruses and SARS-CoV-2, are we ready for the future?
© 2021 Elsevier Masson SAS. All rights reserved..
Influenza viruses and severe acute respiratory syndrome coronavirus 2 are respiratory viruses with a high potential for evolution. Their circulation must be carefully monitored.. The development of diagnostic tools, as well as the search for universal vaccines and new treatments, are strategic tools in public health that allow us to be ready to face future emergencies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Actualites pharmaceutiques - 60(2021), 608 vom: 30. Juli, Seite 28-35 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Virus grippaux et Sars-CoV-2, sommes-nous prêts pour le futur ? |
|---|
| Beteiligte Personen: |
Adnet, Justine [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Diagnosis |
|---|
| Anmerkungen: |
Date Revised 21.12.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.actpha.2021.06.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330053736 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330053736 | ||
| 003 | DE-627 | ||
| 005 | 20231225210451.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.actpha.2021.06.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1100.xml |
| 035 | |a (DE-627)NLM330053736 | ||
| 035 | |a (NLM)34462618 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Adnet, Justine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Influenza viruses and SARS-CoV-2, are we ready for the future? |
| 246 | 3 | 3 | |a Virus grippaux et Sars-CoV-2, sommes-nous prêts pour le futur ? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2021 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a Influenza viruses and severe acute respiratory syndrome coronavirus 2 are respiratory viruses with a high potential for evolution. Their circulation must be carefully monitored.. The development of diagnostic tools, as well as the search for universal vaccines and new treatments, are strategic tools in public health that allow us to be ready to face future emergencies | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a emergence | |
| 650 | 4 | |a influenza | |
| 650 | 4 | |a respiratory virus | |
| 700 | 1 | |a Dina, Julia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Actualites pharmaceutiques |d 1961 |g 60(2021), 608 vom: 30. Juli, Seite 28-35 |w (DE-627)NLM136159966 |x 0515-3700 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2021 |g number:608 |g day:30 |g month:07 |g pages:28-35 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.actpha.2021.06.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2021 |e 608 |b 30 |c 07 |h 28-35 | ||